Evidence map›Paper›PMID 27694827›Full record

ArticleScientific reports2016

Chemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in mice.

Marcel Doerflinger, Jason Glab, Christina Nedeva, Irvin Jose, Ann Lin, Lorraine O'Reilly, Cody Allison, Marc Pellegrini, Richard S Hotchkiss, Hamsa Puthalakath

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Lymphopenia in sepsis: a narrative review.Critical care (London, England) · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Marcel DoerflingerDepartment of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Kingsbury Dr. Victoria 3086, Australia.
Jason GlabDepartment of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Kingsbury Dr. Victoria 3086, Australia.
Christina NedevaDepartment of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Kingsbury Dr. Victoria 3086, Australia.
Irvin JoseDepartment of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Kingsbury Dr. Victoria 3086, Australia.
Ann LinThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Lorraine O'ReillyThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Cody AllisonThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Marc PellegriniThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Richard S HotchkissSchool of Medicine, Department of Anesthesiology, Washington University, 660 South Euclid, St. Louis, MO 63110, USA.
Hamsa PuthalakathDepartment of Biochemistry and Genetics, La Trobe Institute of Molecular Science, La Trobe University, Kingsbury Dr. Victoria 3086, Australia.
La Trobe University · AUWalter and Eliza Hall Institute of Medical Research · AUWashington University in St. Louis · US

Funding

PREVENTION OF APOPTOTIC CELL DEATH IN SEPSIS BY BCL-2R01GM044118 · NIGMS · WASHINGTON UNIVERSITY · PI HOTCHKISS, RICHARD SAMUEL · 1992 to 2017
$2.7M
NIGMS NIH HHS R01 GM044118
6 · The paper itself

Abstract

Sepsis-induced lymphopenia is a major cause of morbidities in intensive care units and in populations with chronic conditions such as renal failure, diabetes, HIV and alcohol abuse. Currently, other than supportive care and antibiotics, there are no treatments for this condition. We developed an in vitro assay to understand the role of the ER-stress-mediated apoptosis process in lymphocyte death during polymicrobial sepsis, which was reproducible in in vivo mouse models. Modulating ER stress using chemical chaperones significantly reduced the induction of the pro-apoptotic protein Bim both in vitro and in mice. Furthermore, in a 'two-hit' pneumonia model in mice, we have been able to demonstrate that administration of the chemical chaperone TUDCA helped to maintain lymphocyte homeostasis by significantly reducing lymphocyte apoptosis and this correlated with four-fold improvement in survival. Our results demonstrate a novel therapeutic opportunity for treating sepsis-induced lymphopenia in humans.

Indexed as

AnimalsApoptosisBcl-2-Like Protein 11Cell LineCell Line, TumorCholagogues and CholereticsDisease Models, AnimalEndoplasmic Reticulum StressFemaleHumansLymphocytesMaleMiceMice, Inbred C57BLMice, KnockoutRAW 264.7 CellsBcl-2-Like Protein 11Cholagogues and CholereticsTaurochenodeoxycholic Acidursodoxicoltaurine

Identifiers

PMID27694827
PMCPMC5046154
OpenAlexW2528309534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.